No-Fault Compensation for Adverse Events Following Immunization: A Review of Chinese Law And Practice
- PMID: 28177508
- DOI: 10.1093/medlaw/fwx001
No-Fault Compensation for Adverse Events Following Immunization: A Review of Chinese Law And Practice
Abstract
In 2005, China introduced an administrative no-fault one-time compensation scheme for adverse events following immunization (AEFI). The scheme aims to ensure fair compensation for those injured by adverse reactions following immunization. These individuals bear a significant burden for the benefits of widespread immunization. However, there is little empirical evidence of how the scheme has been implemented and how it functions in practice. The article aims to fill this gap. Based on an analysis of the legal basis of the scheme and of practical compensation cases, this article examines the structuring, function, and effects of the scheme; evaluates loopholes in the scheme; evaluates the extent to which the scheme has achieved its intended objectives; and discusses further development of the scheme.
Keywords: Adverse event following immunization; Effect; Function; No-fault compensation; Structuring.
© The Author 2017. Published by Oxford University Press; all rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
A review of China's compensation program for adverse reactions following immunization.Front Public Health. 2023 Aug 7;11:1211976. doi: 10.3389/fpubh.2023.1211976. eCollection 2023. Front Public Health. 2023. PMID: 37608980 Free PMC article. Review.
-
Surveillance of adverse events following immunization in China: Past, present, and future.Vaccine. 2015 Jul 31;33(32):4041-6. doi: 10.1016/j.vaccine.2015.04.060. Epub 2015 Apr 28. Vaccine. 2015. PMID: 25936727 Review.
-
The NHS Redress Act 2006 (UK): background and analysis.J Law Med. 2009 Aug;17(1):95-104. J Law Med. 2009. PMID: 19771990
-
NO-FAULT COMPENSATION FOR MEDICAL INJURIES: TRENDS AND CHALLENGES.Med Law. 2014 Dec;33(4):21-53. Med Law. 2014. PMID: 27351046 Review.
-
Compensating Pharmaceutical Injuries in the Absence of Fault.Food Drug Law J. 2014;69(3):447-70, ii. Food Drug Law J. 2014. PMID: 27382858
Cited by
-
Developing an effective and sustainable national immunisation programme in China: issues and challenges.Lancet Public Health. 2022 Dec;7(12):e1064-e1072. doi: 10.1016/S2468-2667(22)00171-2. Epub 2022 Oct 15. Lancet Public Health. 2022. PMID: 36252582 Free PMC article. Review.
-
No-Fault Compensation and Anti-COVID-19 Compulsory Vaccination: The Italian Context in a Broad View.Vaccines (Basel). 2022 Apr 19;10(5):635. doi: 10.3390/vaccines10050635. Vaccines (Basel). 2022. PMID: 35632391 Free PMC article.
-
A solution towards a viable compensation mechanism for injury from COVID-19 vaccines in Malaysia: A qualitative study.Heliyon. 2024 Jan 28;10(3):e25204. doi: 10.1016/j.heliyon.2024.e25204. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38333837 Free PMC article.
-
A review of China's compensation program for adverse reactions following immunization.Front Public Health. 2023 Aug 7;11:1211976. doi: 10.3389/fpubh.2023.1211976. eCollection 2023. Front Public Health. 2023. PMID: 37608980 Free PMC article. Review.
-
Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.Hum Vaccin Immunother. 2020 Mar 3;16(3):602-611. doi: 10.1080/21645515.2019.1664230. Epub 2019 Oct 7. Hum Vaccin Immunother. 2020. PMID: 31589548 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous